Advances in Dementia Treatment – New Hope for Slowing Cognitive Decline

Advances in Dementia Treatment – New Hope for Slowing Cognitive Decline

Dementia, particularly Alzheimer’s disease, has long been viewed as an inevitable decline with limited treatment options. In 2026, that narrative is changing. While our practice specializes in pediatric neurology, many families ask about adult relatives or future risks—here’s what the latest science shows.

The Breakthrough: Disease-Modifying Anti-Amyloid Therapies For the first time, we have FDA-approved medications that target the underlying cause of Alzheimer’s rather than just symptoms:

  • Lecanemab (Leqembi) and Donanemab (Kisunla) – monoclonal antibodies given by IV infusion. These clear amyloid plaques from the brain and slow cognitive decline by about 30% in people with early Alzheimer’s or mild cognitive impairment. Real-world data from 2025 confirms these benefits last beyond clinical trials, giving patients more time with family and independence.

What’s Next in the Pipeline?

  • Oral medications and newer antibodies (like trontinemab with “Brainshuttle” technology) that cross the blood-brain barrier more efficiently with fewer side effects.

  • Therapies targeting tau protein tangles and brain inflammation.

  • Combination approaches (amyloid + tau drugs) and prevention trials for people with early biomarkers but no symptoms yet. Blood-based biomarker tests and advanced imaging are also making early detection easier and more accessible.

Lifestyle Matters More Than Ever

While medications are exciting, brain-healthy habits remain powerful: regular exercise, Mediterranean-style diet, quality sleep, social engagement, and managing blood pressure, diabetes, and hearing loss can reduce dementia risk by up to 40%.

Why This Matters for Families

Even in pediatric neurology, we see rare genetic conditions that cause childhood dementia-like symptoms (e.g., certain storage disorders). Knowledge gained from adult Alzheimer’s research often informs how we approach those complex pediatric cases.

If dementia or memory concerns are affecting your family, our practice offers compassionate guidance and can help coordinate care. Contact us for a consultation—we’re here to support every generation.

Previous
Previous

CGRP Inhibitors – A Game-Changer for Migraine Prevention and Treatment (Especially in Kids and Teens)

Next
Next

Treatment of Parkinson’s Disease – From Symptom Relief to Disease-Modifying Hope in 2026